FDA Approved Liver-Directed Treatment for Metastatic Ocular Melanoma Patients

Delcath Systems announces a new locator on their treatment page for liver-directed treatment of metastatic ocular melanoma.

Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System)

Check this out and share with metastatic #ocularmelanoma patients. Please especially share the news  if they are in need of liver-directed therapy for metastatic ocular melanoma.

From the press release:

“The Healthcare Setting Locator, which the Company will update periodically, is an important tool to assist patients, their caregivers, and their healthcare providers, as they consider appropriate treatment options,” said Kevin Muir, Delcath’s General Manager of U.S. Interventional Oncology. “The previously announced establishment of the permanent J-Code for HEPZATO (J9248) and the launch of the Locator are two important steps in providing information and access to patients for this treatment.”

Read more at the linked article.

https://www.prnewswire.com/news-releases/delcath-systems-announces-healthcare-setting-locator-for-hepzato-kit-melphalanhepatic-delivery-system-302069349.html